financetom
Business
financetom
/
Business
/
Golar LNG Q3 adjusted EBITDA misses estimates
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Golar LNG Q3 adjusted EBITDA misses estimates
Nov 5, 2025 4:17 AM

Overview

* Golar LNG Q3 net income at $31 mln, adjusted EBITDA misses analyst expectations

* Company announces new $150 mln share buyback program

* Golar enters U.S. bond market with $500 mln offering, repays $190 mln maturing bonds

Outlook

* Golar sees annual EBITDA of $400 mln from MKII FLNG charter with SESA

* Company plans to order long lead equipment for next FLNG in Q4 2025

* Golar targets $1.2 bln financing for FLNG Gimi to close in Q4 2025

Result Drivers

* GIMI OPERATIONS - Gimi operations normalized post-COD equipment tuning, with production frequently exceeding base capacity

* MKII FLNG CHARTER - Final Investment Decision and conditions satisfied for 20-year MKII FLNG charter, securing $8 bln adjusted EBITDA backlog

* BOND MARKET ENTRY - Entered U.S. bond market with $500 mln offering, repaid $190 mln maturing bonds

Key Details

Metric Beat/Mis Actual Consensu

s s

Estimate

Q3 $122.53

Operatin mln

g

Revenue

Q3 Net $45.71

Income mln

Q3 Miss $83.42 $89.80

Adjusted mln mln (5

EBITDA Analysts

)

Analyst Coverage

* The current average analyst rating on the shares is "buy" and the breakdown of recommendations is 8 "strong buy" or "buy", 1 "hold" and no "sell" or "strong sell"

* The average consensus recommendation for the oil & gas transportation services peer group is "buy"

* Wall Street's median 12-month price target for Golar LNG Ltd ( GLNG ) is $51.00, about 20.5% above its November 4 closing price of $40.53

* The stock recently traded at 47 times the next 12-month earnings vs. a P/E of 34 three months ago

Press Release:

For questions concerning the data in this report, contact [email protected]. For any other questions or feedback, contact .

(This story was created using Reuters automation and AI based on LSEG and company data. It was checked and edited by a Reuters journalist prior to publication.)

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
MOVES-Citigroup hires Kate Moore from BlackRock as wealth CIO
MOVES-Citigroup hires Kate Moore from BlackRock as wealth CIO
Nov 26, 2024
NEW YORK, Nov 26 (Reuters) - Citigroup ( C/PN ) announced on Tuesday it is hiring Kate Moore as its new wealth division's chief investment officer. Moore is expected to join in February from BlackRock ( BLK ) , where she was most recently portfolio manager and served as head of thematic strategy for the allocation business, according to a...
Anavex Submits Marketing Authorization Application to EU Regulator for Blarcamesine to Treat Alzheimer's; Shares Jump Pre-Bell
Anavex Submits Marketing Authorization Application to EU Regulator for Blarcamesine to Treat Alzheimer's; Shares Jump Pre-Bell
Nov 26, 2024
09:29 AM EST, 11/26/2024 (MT Newswires) -- Anavex Life Sciences ( AVXL ) said Tuesday it filed a marketing authorization application with the European Medicines Agency for blarcamesine to treat Alzheimer's disease. Anavex said that blarcamesine, which is administered orally once a day, showed clinically meaningful improvement over 48 weeks with primary endpoint ADAS-Cog13 score being larger than 2 points....
Arthur J. Gallagher Buys Shepard Insurance for Undisclosed Amount
Arthur J. Gallagher Buys Shepard Insurance for Undisclosed Amount
Nov 26, 2024
09:29 AM EST, 11/26/2024 (MT Newswires) -- Arthur J. Gallagher ( AJG ) said Tuesday it acquired Shepard Insurance, a Connecticut-based retail insurance broker. Financial terms of the deal weren't provided. ...
Actuate Therapeutics to Join Russell 2000 Index; Shares Up Pre-Bell
Actuate Therapeutics to Join Russell 2000 Index; Shares Up Pre-Bell
Nov 26, 2024
09:25 AM EST, 11/26/2024 (MT Newswires) -- Actuate Therapeutics ( ACTU ) said Tuesday it will join the Russell 2000 Index effective after the opening of markets on Dec. 23. The company said it will be added to the index as part of the planned Q4 initial public offering additions. Shares of Actuate Therapeutics ( ACTU ) rose 9.3% in...
Copyright 2023-2026 - www.financetom.com All Rights Reserved